Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322503313> ?p ?o ?g. }
- W4322503313 endingPage "1474" @default.
- W4322503313 startingPage "1474" @default.
- W4322503313 abstract "The enzyme ataxia-telangiectasia mutated (ATM) kinase is a pluripotent signaling mediator which activates cellular responses to genotoxic and metabolic stress. It has been shown that ATM enables the growth of mammalian adenocarcinoma stem cells, and therefore the potential benefits in cancer chemotherapy of a number of ATM inhibitors, such as KU-55933 (KU), are currently being investigated. We assayed the effects of utilizing a triphenylphosphonium-functionalized nanocarrier delivery system for KU on breast cancer cells grown either as a monolayer or in three-dimensional mammospheres. We observed that the encapsulated KU was effective against chemotherapy-resistant mammospheres of breast cancer cells, while having comparably lower cytotoxicity against adherent cells grown as monolayers. We also noted that the encapsulated KU sensitized the mammospheres to the anthracycline drug doxorubicin significantly, while having only a weak effect on adherent breast cancer cells. Our results suggest that triphenylphosphonium-functionalized drug delivery systems that contain encapsulated KU, or compounds with a similar impact, are a useful addition to chemotherapeutic treatment schemes that target proliferating cancers." @default.
- W4322503313 created "2023-02-28" @default.
- W4322503313 creator A5011220101 @default.
- W4322503313 creator A5042762556 @default.
- W4322503313 creator A5048656292 @default.
- W4322503313 creator A5069220763 @default.
- W4322503313 creator A5071471828 @default.
- W4322503313 creator A5079655040 @default.
- W4322503313 creator A5090923833 @default.
- W4322503313 creator A5091537643 @default.
- W4322503313 date "2023-02-25" @default.
- W4322503313 modified "2023-10-16" @default.
- W4322503313 title "A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres" @default.
- W4322503313 cites W1499809894 @default.
- W4322503313 cites W1848123400 @default.
- W4322503313 cites W2005350886 @default.
- W4322503313 cites W2020552396 @default.
- W4322503313 cites W2030240306 @default.
- W4322503313 cites W2034417337 @default.
- W4322503313 cites W2035686223 @default.
- W4322503313 cites W2036575025 @default.
- W4322503313 cites W2046820022 @default.
- W4322503313 cites W2067823097 @default.
- W4322503313 cites W2084610805 @default.
- W4322503313 cites W2086465650 @default.
- W4322503313 cites W2096360042 @default.
- W4322503313 cites W2101988823 @default.
- W4322503313 cites W2111245253 @default.
- W4322503313 cites W2121116603 @default.
- W4322503313 cites W2130363647 @default.
- W4322503313 cites W2149450175 @default.
- W4322503313 cites W2155528804 @default.
- W4322503313 cites W2162325356 @default.
- W4322503313 cites W2162897961 @default.
- W4322503313 cites W2269087766 @default.
- W4322503313 cites W2369146873 @default.
- W4322503313 cites W2418785783 @default.
- W4322503313 cites W2589703983 @default.
- W4322503313 cites W2748840665 @default.
- W4322503313 cites W2766656150 @default.
- W4322503313 cites W2768129107 @default.
- W4322503313 cites W2770686393 @default.
- W4322503313 cites W2775910375 @default.
- W4322503313 cites W2793662549 @default.
- W4322503313 cites W2890307439 @default.
- W4322503313 cites W2918831470 @default.
- W4322503313 cites W2946302521 @default.
- W4322503313 cites W2964471788 @default.
- W4322503313 cites W3018060759 @default.
- W4322503313 cites W3032431568 @default.
- W4322503313 cites W3033287603 @default.
- W4322503313 cites W3040909718 @default.
- W4322503313 cites W3041925007 @default.
- W4322503313 cites W3089116677 @default.
- W4322503313 cites W3090554353 @default.
- W4322503313 cites W3107385845 @default.
- W4322503313 cites W3113350700 @default.
- W4322503313 cites W3120172055 @default.
- W4322503313 cites W3124550366 @default.
- W4322503313 cites W3127551105 @default.
- W4322503313 cites W3137755898 @default.
- W4322503313 cites W3138398102 @default.
- W4322503313 cites W3147395413 @default.
- W4322503313 cites W3160802313 @default.
- W4322503313 cites W3175332634 @default.
- W4322503313 cites W3175739926 @default.
- W4322503313 cites W3183498781 @default.
- W4322503313 cites W3186796533 @default.
- W4322503313 cites W3198064628 @default.
- W4322503313 cites W3200551791 @default.
- W4322503313 cites W3201126704 @default.
- W4322503313 cites W4213127832 @default.
- W4322503313 cites W4221059613 @default.
- W4322503313 cites W4238598813 @default.
- W4322503313 cites W4284698892 @default.
- W4322503313 cites W4285494356 @default.
- W4322503313 cites W4292253860 @default.
- W4322503313 cites W4294163163 @default.
- W4322503313 doi "https://doi.org/10.3390/cancers15051474" @default.
- W4322503313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36900267" @default.
- W4322503313 hasPublicationYear "2023" @default.
- W4322503313 type Work @default.
- W4322503313 citedByCount "0" @default.
- W4322503313 crossrefType "journal-article" @default.
- W4322503313 hasAuthorship W4322503313A5011220101 @default.
- W4322503313 hasAuthorship W4322503313A5042762556 @default.
- W4322503313 hasAuthorship W4322503313A5048656292 @default.
- W4322503313 hasAuthorship W4322503313A5069220763 @default.
- W4322503313 hasAuthorship W4322503313A5071471828 @default.
- W4322503313 hasAuthorship W4322503313A5079655040 @default.
- W4322503313 hasAuthorship W4322503313A5090923833 @default.
- W4322503313 hasAuthorship W4322503313A5091537643 @default.
- W4322503313 hasBestOaLocation W43225033131 @default.
- W4322503313 hasConcept C109316439 @default.
- W4322503313 hasConcept C121608353 @default.
- W4322503313 hasConcept C126322002 @default.
- W4322503313 hasConcept C18150654 @default.
- W4322503313 hasConcept C184235292 @default.